Adverse Event Reporting
VAERS ID | 902491 |
---|---|
Gender | Female |
Age | 41 |
StateCode | NE |
Pharmaceutical Company | PFIZER\BIONTECH |
Lot Number | EH9899 |
Number of vaccinations | 1 |
Vaccinated | 2020-12-15 |
Onset | 2020-12-15 |
Condition | Recovered |
Symptoms
- Headache
- Erythema
- Dizziness
- Dyspnoea
- Blood pressure increased
- Nausea
Current Illness
Preexisting Conditions
Arrhythmia - right bundle branch block. GERD (gastroesophageal reflux disease) Spinal headache headache with steroid injection to the back. Uses contact lenses
Other Medications
DULOXETINE (CYMBALTA) 60 MG CAPSULE Take 1 capsule (60 mg total) by mouth once daily at bedtime HYDROCODONE-ACETAMINOPHEN (NORCO) 5-325 MG TABLET Take 1 tablet by mouth once a day as needed for moderate to severe pain, with allowance
Previous Vaccinations
Allergies
Gabapentin Adhesive Duloxetine
Laboratory Data
Write-up
Within a few minutes of receiving the COVID 19 vaccination, patient developed lightheadedness, shortness of breath, headache, and some nausea.
She did get some redness to her neck and upper chest.
No recent illness.
Had elevated BPs ranged from 158/103 to 207/126 .
HR ranged from 82-106.
O2 sats always > 96%.
Temp 37.
1 C.
Received Tylenol 1000 mg PO, Dexamethasone 10 mg IV, diphenhydramine 50 mg IV, famotidine 20 mg IV, ketorolac 30 mg IV, ondansetron 4 mg IV, and 1 L NS.
Patient prescribed EpiPen and prednisone and discharged.